Latest News and Press Releases
Want to stay updated on the latest news?
-
REPEAT – Gold and Antimony in One Permit: Rua Gold’s Positive PEA Lands in a Fast-Track Jurisdiction
VANCOUVER, British Columbia, June 08, 2026 (GLOBE NEWSWIRE) -- Canada News Group News Commentary – Two of the tightest stories in metals — record-setting gold and critically short antimony — just...
-
TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- Argo Corporation (TSXV: ARGH) (OTCQX: ARGHF) (“Argo” or the “Company”), a leader in next-generation transit solutions, today announced a $4.5 million...
-
Issued on behalf of GT Biopharma, Inc. (Nasdaq: GTBP) A clinical-stage immuno-oncology company has moved three drug candidates into human testing over time --- and most recently expanded into solid...
-
On June 4, 2026 Charlie’s Stockholders overwhelmingly approved a proxy proposal to give the Board of Directors discretionary authority to initiate a reverse stock split; this measure will facilitate...
-
RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company and the only vertically integrated...
-
Atlanta, Georgia, June 08, 2026 (GLOBE NEWSWIRE) -- Outdoor Holding Company (NASDAQ: POWW/POWWP) (“Outdoors Online,” “we,” “us.” “our” or the “Company”), the owner of GunBroker.com, the largest...
-
COMMERCE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- FDH Aero (“FDH” or the “Company”), a leading global provider of supply chain solutions for the aerospace and defense industry, today announced...
-
Toronto, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- Fort Technology Inc. (Nasdaq: FRTT, TSXV:FORT) (“Fort” or the “Company”) is pleased to announce that its common shares will commence trading on...
-
Suominen Corporation, inside information, June 8, 2026 at 3:45 p.m. (EEST) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN,...
-
Alkeus Pharmaceuticals announces first patient dosed in pivotal global Phase 3 NORTHSTAR Study of oral gildeuretinol in Stargardt disease.